|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133 04180
|
$145,295
|
Linet, Martha
|
DCEG (NCI)
|
|
Cancer Center Support Grant
|
3P30CA042014-29S1
|
$125,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S2
|
$250,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S3
|
$248,625
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S4
|
$114,251
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S5
|
$59,693
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S6
|
$155,422
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S7
|
$171,608
|
ULRICH, CORNELIA
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S8
|
$151,649
|
ULRICH, CORNELIA
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-29S9
|
$228,331
|
ULRICH, CORNELIA
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-29
|
$2,284,970
|
ULRICH, CORNELIA
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA091842-17S1
|
$240,897
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-17S2
|
$254,917
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-17S3
|
$199,999
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-17S4
|
$124,730
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA091842-17
|
$4,207,812
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Risk in Myotonic Dystrophy
|
ZIA CP010144 10568
|
$153,082
|
Gadalla, Shahinaz
|
DCEG (NCI)
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-28
|
$5,637,954
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-28S1
|
$249,965
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cataract after low dose and low dose rate exposure
|
ZIA CP010133 10717
|
$16,720
|
Little, Mark
|
DCEG (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$440,152
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Contribution of Gynecologic and Breast Cancer Biospecimens from African American women to HCMI
|
3P30CA043703-28S2
|
$48,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
DEFINING RISK FACTORS FOR NF1-OPTIC GLIOMA
|
5R01CA214146-03
|
$348,844
|
GUTMANN, DAVID
|
WASHINGTON UNIVERSITY
|
|
Development of an a MC1R selective companion diagnostic imaging probe
|
1R43CA235992-01
|
$248,155
|
WATERHOUSE, RIKKI
|
MODULATION THERAPEUTICS, INC.
|
|
DICER1-Related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural
|
ZIA CP010144 10548
|
$806,243
|
Stewart, Douglas
|
DCEG (NCI)
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,141,540
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Evaluation of an OCA2 enhancer variant as a modifier of the phenotype of BAP1-Tumor predisposition syndrome
|
1R21CA219884-01A1
|
$203,471
|
ABDEL-RAHMAN, MOHAMED
|
OHIO STATE UNIVERSITY
|
|
Families at high risk of cancer
|
ZIA CP004410 08285
|
$76,748
|
Savage, Sharon
|
DCEG (NCI)
|
|
Flow Cytometric Detection of Malignant Cells in Body Fluids
|
ZIC BC 011093
|
$173,564
|
Stetler-Stevenson, Maryalice
|
CCR (NCI)
|
|
Genomics of multiple primary tumors
|
ZIA CP010131 10782
|
$30,751
|
Morton, Lindsay
|
DCEG (NCI)
|
|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-05
|
$701,988
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Humanized Anti-Renalase Antibodies for Unresectable Melanoma
|
1R43CA224463-01
|
$299,996
|
BERKOWITZ, BARRY
|
BESSOR PHARMA, LLC
|
|
Identifying a nodal point for G alpha q signaling in eye disease
|
5R01CA202778-03
|
$340,838
|
ODELBERG, SHANNON
|
UNIVERSITY OF UTAH
|
|
Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis
|
5R01CA176001-05
|
$323,700
|
GROSSNIKLAUS, HANS
|
EMORY UNIVERSITY
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$474,287
|
Daar, Ira
|
CCR (NCI)
|
|
Molecular Genetics of Melanoma
|
5K24CA149202-09
|
$170,091
|
TSAO, HENSIN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Molecular Mechanism and Therapy for Ocular Melanoma
|
5R01CA217642-02
|
$488,005
|
ZHANG, KANG
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Molecular Predictive Testing in Ocular Melanoma
|
5R01CA125970-12
|
$572,813
|
HARBOUR, JAMES
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$880,303
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Non-canonical WNT signaling in the invasion and metastasis of uveal melanoma
|
5F30CA217184-02
|
$34,824
|
RICHARDS, JACKSON
|
UNIVERSITY OF UTAH
|
|
Noninvasive Contrast Enhanced Early Detection of Melanoma Liver Metastasis
|
5R42CA183376-03
|
$728,995
|
YANG, JENNY
|
INLIGHTA BIOSCIENCES, LLC
|
|
Proteomics of Metastatic and Non-Metastatic Uveal Melanoma
|
5R21CA209500-02
|
$172,369
|
CRABB, JOHN
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Regulation of Ciliogenesis and Ciliary-related signaling
|
ZIA BC 011398
|
$1,100,630
|
Westlake, Christopher
|
CCR (NCI)
|
|
REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF
|
5R01CA193321-04
|
$362,569
|
MITSIADES, NICHOLAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIA BC 010958
|
$474,287
|
Daar, Ira
|
CCR (NCI)
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-32S1
|
$92,737
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|